✦ LIBER ✦

Impact of Pharmacogenetics and Therapeutic Drug Monitoring On Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation

✍ Scribed by Teusink, Ashley; Vinks, Alexander; Zhang, Kejian; Davies, Stella; Filipovich, Lisa; Fukuda, Tsuyoshi; Nortman, Shannon; Kissell, Diane; Dell, Sarah; Rhollans, Lindsay; Mehta, Parinda A.

Book ID: 123079035
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 130 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2012.11.162

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenetic Directed Dosing Leads to

Pharmacogenetic Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplants

✍ Teusink, Ashley; Vinks, Alexander; Zhang, Kejian; Fukuda, Tsuyoshi; Davies, Stel 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 409 KB

The Schedule and Dose of Alemtuzumab Det

The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation

✍ Marsh, Rebecca A.; Kim, Mi-Ok; Liu, Chunyan; Bellman, Denise; Hart, Laura; Jorda 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Aprepitant Pharmacokinetics and Assessin

Aprepitant Pharmacokinetics and Assessing the Impact of Aprepitant on Cyclophosphamide Metabolism in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation

✍ Bubalo, Joseph S.; Cherala, Ganesh; McCune, Jeannine S.; Munar, Myrna Y.; Tse, S 📂 Article 📅 2012 🏛 Sage Publications 🌐 English ⚖ 404 KB

Effect of CD34+ cell dose on hematopoiet

Effect of CD34+ cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

✍ Jens Klaus; Doris Herrmann; Iris Breitkreutz; Ute Hegenbart; Uta Mazitschek; Ger 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

Relative Impact of Psychosocial Factors,

Relative Impact of Psychosocial Factors, Comorbidities, and Disease Risk on the Utilization of Resources and Overall Outcome in Patients Undergoing Hematopoietic Stem Cell Transplantation

✍ D.S. Speckhart; H.K. Holland; S.R. Solomon; A. Bashey; L.E. Morris; L. Kerns; T. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A Phase II study on the safety and effic

A Phase II study on the safety and efficacy of a single dose of pegfilgrastim for mobilization and transplantation of autologous hematopoietic stem cells in pediatric oncohematology patients

✍ Simone Cesaro; Andrea Giulio Zanazzo; Stefano Frenos; Roberto Luksch; Anna Pegor 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 86 KB